Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial

Background: Previously we have shown that early development of rash is associated with a higher chance of achieving pathological complete response to neoadjuvant lapatinib. In the current analysis, we investigate its impact on survival in the ALTTO phase III adjuvant trial. Methods: In ALTTO, patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Natl Cancer Inst
Autors principals: Sonnenblick, Amir, de Azambuja, Evandro, Agbor-tarh, Dominique, Bradbury, Ian, Campbell, Christine, Huang, Yingjie, Dueck, Amylou C., Pritchard, Kathleen I., Wolff, Antonio C., Jackisch, Christian, Lang, Istvan, Untch, Michael, Smith, Ian, Boyle, Frances, Xu, Binghe, Gomez, Henry, Perez, Edith A., Piccart, Martine, Azim, Hatem A.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5017935/
https://ncbi.nlm.nih.gov/pubmed/27098150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw037
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars